Verisante Technology Inc. (VRSEF)
USD 0.01
(233.33%)
USD 0.01
(233.33%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -90.52 Thousand CAD | -107.53% |
| 2022 | 1.2 Million CAD | 725.01% |
| 2021 | -192.25 Thousand CAD | -337.3% |
| 2020 | -43.96 Thousand CAD | 11.43% |
| 2019 | -49.63 Thousand CAD | -111.51% |
| 2018 | 431.36 Thousand CAD | 118.92% |
| 2017 | -2.27 Million CAD | -38.87% |
| 2016 | -1.64 Million CAD | 31.3% |
| 2015 | -2.38 Million CAD | 26.1% |
| 2014 | -3.23 Million CAD | 33.96% |
| 2013 | -4.89 Million CAD | -39.46% |
| 2012 | -3.51 Million CAD | 1.13% |
| 2011 | -3.55 Million CAD | -139.19% |
| 2010 | -1.48 Million CAD | -72.28% |
| 2009 | -861.76 Thousand CAD | 2.64% |
| 2008 | -885.11 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -28.44 Thousand CAD | 11.4% |
| 2024 Q1 | -32.1 Thousand CAD | 15.22% |
| 2023 Q3 | 14.15 Thousand CAD | 145.5% |
| 2023 FY | -90.52 Thousand CAD | -107.53% |
| 2023 Q4 | -37.86 Thousand CAD | -367.55% |
| 2023 Q1 | -35.7 Thousand CAD | -102.55% |
| 2023 Q2 | -31.1 Thousand CAD | 12.89% |
| 2022 Q1 | -57.67 Thousand CAD | 33.66% |
| 2022 Q4 | 1.4 Million CAD | 1880.69% |
| 2022 Q2 | -63.24 Thousand CAD | -9.66% |
| 2022 Q3 | -78.68 Thousand CAD | -24.42% |
| 2022 FY | 1.2 Million CAD | 725.01% |
| 2021 Q4 | -86.93 Thousand CAD | -129.21% |
| 2021 FY | -192.25 Thousand CAD | -337.3% |
| 2021 Q1 | -33.49 Thousand CAD | 0.0% |
| 2021 Q2 | -33.88 Thousand CAD | -1.17% |
| 2021 Q3 | -37.93 Thousand CAD | -11.93% |
| 2020 FY | -43.96 Thousand CAD | 11.43% |
| 2019 FY | -49.63 Thousand CAD | -111.51% |
| 2018 FY | 431.36 Thousand CAD | 118.92% |
| 2017 FY | -2.27 Million CAD | -38.87% |
| 2017 Q2 | -282.94 Thousand CAD | 22.36% |
| 2017 Q3 | -226.97 Thousand CAD | 19.78% |
| 2017 Q1 | -364.41 Thousand CAD | 16.32% |
| 2017 Q4 | -1.4 Million CAD | -519.13% |
| 2016 Q4 | -435.5 Thousand CAD | -26.13% |
| 2016 FY | -1.64 Million CAD | 31.3% |
| 2016 Q3 | -345.26 Thousand CAD | 17.25% |
| 2016 Q1 | -443.57 Thousand CAD | 42.84% |
| 2016 Q2 | -417.24 Thousand CAD | 5.94% |
| 2015 Q2 | -402.13 Thousand CAD | 42.47% |
| 2015 Q4 | -776 Thousand CAD | -51.43% |
| 2015 FY | -2.38 Million CAD | 26.1% |
| 2015 Q1 | -698.98 Thousand CAD | 12.13% |
| 2015 Q3 | -512.45 Thousand CAD | -27.43% |
| 2014 Q2 | -678.73 Thousand CAD | 34.81% |
| 2014 FY | -3.23 Million CAD | 33.96% |
| 2014 Q1 | -1.04 Million CAD | 43.12% |
| 2014 Q4 | -795.51 Thousand CAD | -10.81% |
| 2014 Q3 | -717.92 Thousand CAD | -5.77% |
| 2013 Q1 | -1.17 Million CAD | 13.22% |
| 2013 Q3 | -749.03 Thousand CAD | 34.29% |
| 2013 FY | -4.89 Million CAD | -39.46% |
| 2013 Q4 | -1.83 Million CAD | -144.4% |
| 2013 Q2 | -1.13 Million CAD | 3.12% |
| 2012 Q4 | -1.35 Million CAD | -93.6% |
| 2012 Q1 | -795.29 Thousand CAD | 25.36% |
| 2012 Q3 | -700.32 Thousand CAD | -6.22% |
| 2012 FY | -3.51 Million CAD | 1.13% |
| 2012 Q2 | -659.29 Thousand CAD | 17.1% |
| 2011 Q3 | -987.66 Thousand CAD | -30.08% |
| 2011 Q2 | -759.26 Thousand CAD | -2.8% |
| 2011 FY | -3.55 Million CAD | -139.19% |
| 2011 Q1 | -738.61 Thousand CAD | -70.25% |
| 2011 Q4 | -1.06 Million CAD | -7.88% |
| 2010 Q2 | -352.45 Thousand CAD | -11.13% |
| 2010 Q1 | -317.14 Thousand CAD | -78.76% |
| 2010 Q4 | -433.83 Thousand CAD | -13.82% |
| 2010 FY | -1.48 Million CAD | -72.28% |
| 2010 Q3 | -381.16 Thousand CAD | -8.15% |
| 2009 Q1 | -213.74 Thousand CAD | 1.18% |
| 2009 FY | -861.76 Thousand CAD | 2.64% |
| 2009 Q4 | -177.41 Thousand CAD | 10.1% |
| 2009 Q3 | -197.35 Thousand CAD | 27.78% |
| 2009 Q2 | -273.25 Thousand CAD | -27.85% |
| 2008 Q3 | -244.01 Thousand CAD | 0.0% |
| 2008 FY | -885.11 Thousand CAD | 0.0% |
| 2008 Q4 | -216.3 Thousand CAD | 11.36% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -1.16 Million USD | 92.23% |
| SS Innovations International, Inc. | -20.94 Million USD | 99.568% |
| Össur hf. | 58.38 Million USD | 100.155% |
| Össur hf. | 58.38 Million USD | 100.155% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| QHSLab, Inc. | -468.36 Thousand USD | 80.672% |
| BrainsWay Ltd. | -4.19 Million USD | 97.843% |
| BioElectronics Corporation | -722.81 Thousand USD | 87.476% |
| AVITA Medical, Inc. | -39.16 Million USD | 99.769% |
| Zecotek Photonics Inc. | -3.51 Million USD | 97.428% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| Wellstar International, Inc. | -3.1 Million USD | 97.088% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | 85.087% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 103.849% |
| Escalon Medical Corp. | -125.26 Thousand USD | 27.731% |
| Aurora Spine Corporation | -1.68 Million USD | 94.613% |
| NewCardio, Inc. | -11.49 Million USD | 99.213% |
| Avitar, Inc. | -2.25 Million USD | 95.994% |
| Vivos Inc. | -2.89 Million USD | 96.873% |
| Theraclion SA | -3.67 Million USD | 97.537% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | 58.564% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| REMSleep Holdings, Inc. | -1.77 Million USD | 94.908% |
| Positron Corporation | -1.63 Million USD | 94.476% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | 78.345% |
| Nanomix Corporation | -12.33 Million USD | 99.266% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | 87.978% |
| Stratec SE | 14.42 Million USD | 100.628% |
| Heart Tronics, Inc. | -13.32 Million USD | 99.321% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | 27.883% |
| Electromedical Technologies, Inc. | -2.64 Million USD | 96.573% |
| Lombard Medical, Inc. | -31.03 Million USD | 99.708% |
| ALR Technologies Inc. | -11.89 Million USD | 99.239% |
| MicroPort Scientific Corporation | -477.62 Million USD | 99.981% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -29.895% |
| VMS Rehab Systems, Inc. | 46.44 USD | 195028.941% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 99.355% |
| Guided Therapeutics, Inc. | -3.48 Million USD | 97.405% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 99.649% |
| Ingen Technologies, Inc. | -5.06 Million USD | 98.211% |
| United American Healthcare Corporation | 723 Thousand USD | 112.521% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | 90.006% |
| IR-Med Inc. | -4.9 Million USD | 98.156% |
| Polarean Imaging plc | -11.88 Million USD | 99.238% |
| ECGI Holdings, Inc. | -3.61 Million USD | 97.493% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | 86.243% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | 87.372% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 122.927% |
| Urologix, Inc. | -7.6 Million USD | 98.81% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | 94.656% |
| Nexeon MedSystems Inc. | -2.17 Million USD | 95.843% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | 88.755% |
| Smith & Nephew plc | 263 Million USD | 100.034% |
| NIOX Group Plc | 13.64 Million USD | 100.664% |
| Fuse Medical, Inc. | 1.45 Million USD | 106.2% |
| Broncus Holding Corporation | -28.09 Million USD | 99.678% |
| Brain Scientific Inc. | -12.34 Million USD | 99.267% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 99.691% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | 43.509% |